<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03079206</url>
  </required_header>
  <id_info>
    <org_study_id>2016-02152</org_study_id>
    <nct_id>NCT03079206</nct_id>
  </id_info>
  <brief_title>Basophile Activation Testing (BAT) in Hazelnut Allergy (Hazelnut BAT Study)</brief_title>
  <official_title>Correlation of the in Vivo Food Provocation Test With the in Vitro Basophile Activation Test in Hazelnut Allergic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ADR-AC Laboratory, Berne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study intends to compare the outcome of food challenge in hazelnut allergic&#xD;
      patients with the outcome of basophile activation tests using hazelnut extract and&#xD;
      components.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Accurate diagnosis of food allergy depends on food challenge outcome. The proposed study&#xD;
      intends to compare the outcome of food challenge in hazelnut allergic patients with the&#xD;
      outcome of basophile activation tests using hazelnut extract and components to evaluate the&#xD;
      diagnostic utility of basophile activation testing.&#xD;
&#xD;
      With a view towards improved in vitro diagnostic methods, the investigators intend to&#xD;
      evaluate the diagnostic potential of basophile activation testing in patients with hazelnut&#xD;
      allergy confirmed by a positive provocation or supported by a convincing history of&#xD;
      anaphylactic reaction(s) to hazelnut in the past, patients with pollinosis but no symptoms of&#xD;
      hazelnut allergy and non-atopic control subjects.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 22, 2017</start_date>
  <completion_date type="Actual">November 10, 2020</completion_date>
  <primary_completion_date type="Actual">November 10, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>The study intends to compare the outcome of food challenge with hazelnut and the in vitro basophile activation test using hazelnut extract and allergens</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>In terms of study inclusion there will be no masking. Only the food challenge itself will be masked.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with challenge confirmed food allergy to hazelnut and a positive basophile activation test</measure>
    <time_frame>up to 3 years</time_frame>
    <description>outcome of food challenge in hazelnut allergic patients will be compared to the outcome of basophile activation using hazelnut extract and allergens</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">83</enrollment>
  <condition>Food Allergy</condition>
  <arm_group>
    <arm_group_label>Hazelnut allergy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with positive case history of hazelnut allergy and a positive skin testing are undergoing a food challenge and blood sampling for basophile activation testing</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Food challenge</intervention_name>
    <description>food challenge with hazelnut</description>
    <arm_group_label>Hazelnut allergy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>skin testing</intervention_name>
    <description>Skin testing with hazelnut extract</description>
    <arm_group_label>Hazelnut allergy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>blood sampling</intervention_name>
    <description>blood sampling to perform basophile activation tests</description>
    <arm_group_label>Hazelnut allergy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Primary Inclusion criteria:&#xD;
&#xD;
          -  Male and female subjects, age ≥ 14 years&#xD;
&#xD;
          -  Informed Consent as documented by signature&#xD;
&#xD;
        Secondary inclusion criterion&#xD;
&#xD;
          -  Group A: positive case history of allergic reaction(s) to hazelnut positive&#xD;
             double-blind placebo-controlled food challenge with hazelnut or positive titrated open&#xD;
             food challenge with hazelnut or unambiguous case history of an anaphylactic reaction&#xD;
             after hazelnut will be included without provocation&#xD;
&#xD;
          -  Group B:positive skin test (SPT) with birch pollen and hazelnut and negative food&#xD;
             provocation with hazelnut.&#xD;
&#xD;
          -  Group C: negative case history of hazelnut and birch allergy and negative skin test&#xD;
             (SPT) with hazelnut and birch pollen and negative food provocation with hazelnut&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Drugs not allowed due to interference with the food challenge (or shortest interval&#xD;
             between last treatment and food challenge): corticosteroids systemically (2 weeks),&#xD;
             antihistamines (3 days), beta blocker (1 day), angiotensin converting enzyme (ACE)&#xD;
             inhibitors (2 days), omalizumab (2 months)&#xD;
&#xD;
          -  Women who are pregnant&#xD;
&#xD;
          -  Lack of safe contraception&#xD;
&#xD;
          -  Uncontrolled asthma, forced expiratory volume (1 second) &lt;70% predicted value&#xD;
&#xD;
          -  Acute allergic disease&#xD;
&#xD;
          -  Chronic urticaria&#xD;
&#xD;
          -  Mastocytosis&#xD;
&#xD;
          -  Other clinically significant concomitant disease states&#xD;
&#xD;
          -  Known or suspected non-compliance, drug or alcohol abuse,&#xD;
&#xD;
          -  Inability to follow the procedures of the study&#xD;
&#xD;
          -  Participation in another study with investigational drug within the 30 days preceding&#xD;
             and during the present study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara Ballmer-Weber, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Allergy Unit, Department of Dermatology, University Zürich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Allergy Unit, Department of Dermatology, University Hospital</name>
      <address>
        <city>Zürich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>February 20, 2017</study_first_submitted>
  <study_first_submitted_qc>March 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 14, 2017</study_first_posted>
  <last_update_submitted>November 12, 2020</last_update_submitted>
  <last_update_submitted_qc>November 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hazelnut</keyword>
  <keyword>allergens</keyword>
  <keyword>basophile-activation-test</keyword>
  <keyword>food</keyword>
  <keyword>allergy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Food Hypersensitivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

